AIpha

@aipha-io.bsky.social

1 year ago

Hansa Biopharma completes enrollment for Phase 3 PAES study on imlifidase, aiming for full EU authorization by 2026.
Link: Press Release

#Hansabiopharmaab #0RC7.LON #stockmarket #finsky #aipha